Skip to main content

Primary myelofibrosis

Primary myelofibrosis is a condition characterised by the buildup of scar tissue (fibrosis) in the bone marrow, the tissue that produces blood cells. Because of the fibrosis, the bone marrow is unable to make enough normal blood cells. The shortage of blood cells causes many of the signs and symptoms of primary myelofibrosis.

Description

Primary myelofibrosis is a condition characterised by the buildup of scar tissue (fibrosis) in the bone marrow, the tissue that produces blood cells. Because of the fibrosis, the bone marrow is unable to make enough normal blood cells. The shortage of blood cells causes many of the signs and symptoms of primary myelofibrosis.

Initially, most people with primary myelofibrosis have no signs or symptoms. Eventually, fibrosis can lead to a reduction in the number of red blood cells, white blood cells, and platelets. A shortage of red blood cells (anaemia) often causes extreme tiredness (fatigue) or shortness of breath. A loss of white blood cells can lead to an increased number of infections, and a reduction of platelets can cause easy bleeding or bruising.

Because blood cell formation (hematopoiesis) in the bone marrow is disrupted, other organs such as the spleen or liver may begin to produce blood cells. This process, called extramedullary hematopoiesis, often leads to an enlarged spleen (splenomegaly) or an enlarged liver (hepatomegaly). People with splenomegaly may feel pain or fullness in the abdomen, especially below the ribs on the left side. Other common signs and symptoms of primary myelofibrosis include fever, night sweats, and bone pain.

Primary myelofibrosis is most commonly diagnosed in people aged 50 to 80 but can occur at any age.

Inheritance patterns

The source lists the following possible inheritance patterns: Not inherited. More than one pattern can apply in different cases.

Other names

Agnogenic myeloid metaplasia

Chronic idiopathic myelofibrosis

Idiopathic myelofibrosis

Myelofibrosis with myeloid metaplasia

Myeloid metaplasia

Patient picks for Genetic conditions

Related patient information and medicines

Myelofibrosis

Patient information leaflet

Myelofibrosis

Myelofibrosis is a condition affecting the bone marrow and its blood cell production. What is mye... Myelofibrosis belongs to a group of diseases called myeloproliferative disorders. Myelofibrosis is a serious bone marrow disorder that disrupts your body's normal production of blood cells. What causes myelofibrosis. Myelofibrosis which occurs.

Chronic myeloid leukaemia

Patient information leaflet

Chronic myeloid leukaemia

Chronic myeloid leukaemia (CML) is sometimes called chronic myelogenous leukaemia, chronic granulocytic leukaemia, or chronic myelocytic leukaemia. What is chronic myeloid leukaemia. In this phase there are more than 30% blast cells in the blood and bone marrow. Very rarely, CML develops into a condition called myelofibrosis. This means that the.

Polycythaemia rubra vera

Patient information leaflet

Polycythaemia rubra vera

Polycythaemia rubra vera (PRV) is a myeloproliferative disorder, which means the bone marrow makes too many blood cells. Gout Myelofibrosis There is a chance that, after about 15 years, PRV can develop into a condition known as myelofibrosis. Dr Krishna Vakharia , 24th November 2023 The National Institute for Health and Care Excellence (NICE) has.

Liver function tests

Patient information leaflet

Liver function tests

Alpha-1 antitrypsin Alpha-1 antitrypsin deficiency (a hormone involved in protecting liver and lung cells from injury). Clotting factors Blood clotting tests (particularly if there is a suspicion that your blood is not clotting well or you have severe liver disease). Enhanced liver fibrosis score (ELF) -this is a set of three tests that can.

Jaundice

Patient information leaflet

Jaundice

Alcoholic hepatitis. Autoimmune hepatitis. Inflammation caused by poisons or as a side-effect of some medicines. Cirrhosis Cirrhosis. This is a condition where normal liver tissue is replaced by scar tissue (fibrosis). It tends to progress slowly and often does not cause symptoms in its early stages. However, as the function of the liver gradually.

Primary sclerosing cholangitis

Patient information leaflet

Primary sclerosing cholangitis

Primary sclerosing cholangitis is an uncommon condition affecting the bile ducts and liver. Inflammation and scarring of the bile ducts can lead to liver damage and cirrhosis - a condition where normal liver tissue is replaced by scar tissue (fibrosis). Different treatments are available to control symptoms that may develop and also to manage any.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 18 Aug 2020 | Latest version
  • 1 Sept 2014 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.